Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

UKONS 2017 | The adapting role of the cancer nurse: immunotherapy

Elaine Vickers • 10 Nov 2017
UKONS 2017
General

Immunotherapy has received a lot of coverage as a revolutionary cancer treatment, in both the medical community and in the mainstream media, and it is likely that this trend will continue in the coming years. In this interview, Elaine Vickers, PhD, of Science Communicated Ltd, Manchester, UK, explains how this will affect cancer nurses, in terms of knowledge of the immune system and the mechanism of action of these drugs to be able to answer their patients’ queries and concerns. This interview was recorded at the UK Oncology Nursing Society (UKONS) Annual Conference 2017, held in Harrogate, UK.

More from Elaine Vickers

Immunotherapy in precision cancer medicine
3:25
Immunotherapy in precision cancer medicine
Elaine Vickers • 5 Oct 2021
Approaches to improving response rates from immunotherapy
2:12
Approaches to improving response rates from immunotherapy
Elaine Vickers • 16 Nov 2018
NCRI educational session initiatives
1:23
NCRI educational session initiatives
Elaine Vickers • 15 Nov 2018
Making the patient voice heard
1:14
Making the patient voice heard
Elaine Vickers • 15 Nov 2018

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals